BioAtla, Inc. (BCAB) Reports In-Line Q3 EPS

BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• BNP Paribas Exane Upgrades Holcim Ltd (HOLN:SW) to Outperform
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS